alexa Saurabh Agarwal | Baylor College of Medicine
ISSN: 2475-3203

Journal of Brain Tumors & Neurooncology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Saurabh Agarwal

Saurabh Agarwal Editor
Saurabh Agarwal
Department of Pediatric Hematology-Oncology
Texas Children's Cancer Center
Baylor College of Medicine

With a great interest in human diseases and the mechanisms controlling them, I investigated the role of specific signaling mechanisms that drive cancer stem cell (CSC) driven tumorigenesis and metastasis in pediatric cancer neuroblastoma. As a postdoctoral fellow at Department of Pediatrics, Baylor College of Medicine, I discovered a novel cancer stem cell-like cells marked by G-CSFR (CD114+) in neuroblastoma using in vitro and in vivo models. I further expanded my research to establish the role of G-CSF as a neuroblastoma cancer stem cell specific growth factor. In addition, I successfully collaborated with other researchers and produced several peer-reviewed publications in the area of neuroblastoma cancer biology. During my initial postdoctoral training at INSERM, Paris, France, I was involved in the studies of Transferrin Receptor1 (TfR1) and an anti-TfR antibody as a therapeutic molecule in different human diseases. These studies leads to two major publications in the field. During my doctoral research training at University of Lucknow, India, I developed synthetic human alpha-1-antitrypsin (rhAAT) gene and achieved high-level expression to inexpensively produce bio-similar hAAT for therapeutic purposes. I have developed protein engineered variants of hAAT for increased biological activity and stability. I first authored three research articles, co-authored a research article and a review article describing the findings of my doctoral research. 

Research Interest

Cancer Therapy, Solid Tumor, Epigenetics, Cancer stem cell, Pediatrics cancer, Neuroblastoma, Neurooncology, Immunotherapy, STAT3 Pathway, p53, MYCN, Apoptosis, Cell Cycle, Epigenetic inhibitors

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version